NCT00046150已完成3 期
12-Week, Multinational, Multicenter, Controlled, Open, 1:1 Randomized, Parallel Clinical Trial Comparing the Safety of HMR1964 and Insulin Aspart Used in Continuous Subcutaneous Insulin Infusion (CSII) in Subjects With Type 1 Diabetes Mellitus
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Sanofi
- 入组人数
- 59
- 试验地点
- 4
- 主要终点
- Frequency of catheter occlusions
研究概览
简要总结
The purpose of this study is to compare the safety of HMR 1964 and insulin aspart when used in external pumps with respect to catheter occlusions, GHb assessment, insulin doses, blood glucose parameters, hypoglycemic episodes, unexplained hyperglycemia, adverse events, laboratory data, and vital signs.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Frequency of catheter occlusions
次要结局
- Unexplained hyperglycemia, parameters of glycemic control
研究者
研究点 (4)
Loading locations...
相似试验
已完成
3 期
Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes MellitusDiabetes Mellitus, Type 1NCT00290979Sanofi250
已完成
2 期
Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes SubjectsType 2 DiabetesNCT06688123Jiangsu HengRui Medicine Co., Ltd.275
已完成
3 期
Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT00290927Sanofi390
已完成
4 期
Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 DiabetesDiabetes Mellitus, Type 2DiabetesNCT00274274Novo Nordisk A/S373
已完成
3 期
Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin PumpDiabetes Type 1NCT02546401University Hospital, Brest22